MALLINCKRODT PLC

In News

Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides 2025 Guidance - PR Newswire

PR Newswire - Mar 13, 2025

Drugmakers Mallinckrodt, Endo in talks to merge, source says - Reuters

Reuters - Mar 12, 2025

Mallinckrodt Execs See Securities Fraud Claims Trimmed - Law360

Law360 - Jul 02, 2025

Mallinckrodt Pharmaceuticals successfully completes USD925 million carve-out sale of Therakos Business with support from A&O Shearman - A&O Shearman

A&O Shearman - Dec 16, 2024

Mallinckrodt plc Reports First Quarter 2025 Financial Results and Reaffirms Full-Year Guidance - PR Newswire

PR Newswire - May 06, 2025

Mallinckrodt plc’s $6.7 billion merger with Endo, Inc. - Arthur Cox LLP

Arthur Cox LLP - Mar 14, 2025

Q1 2025 Earnings Preview: Mallinckrodt Sets Date for Critical Financial Update - Stock Titan

Stock Titan - Apr 10, 2025

Mallinckrodt and Endo to merge - Drug Store News

Drug Store News - Mar 13, 2025

Drugmakers Mallinckrodt, Endo to Merge, Plan NYSE Listing - Investopedia

Investopedia - Mar 13, 2025

Mallinckrodt and Endo Agree to Combine - Contract Pharma

Contract Pharma - Mar 13, 2025

Mallinckrodt and Endo to combine after emerging from bankruptcy linked to opioid crisis - Financial Times

Financial Times - Mar 13, 2025

Mallinckrodt plc to Report Fourth Quarter and Fiscal Year 2024 Financial Results - PR Newswire

PR Newswire - Feb 27, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.